Process For Production Of Polypeptide By Regulation Of Assembly - EP3050963

The patent EP3050963 was granted to Chugai Seiyaku Kabushiki Kaisha on Sep 18, 2019. The application was originally filed on Mar 31, 2006 under application number EP15194500A. The patent is currently recorded with a legal status of "Revoked".

EP3050963

CHUGAI SEIYAKU KABUSHIKI KAISHA
Application Number
EP15194500A
Filing Date
Mar 31, 2006
Status
Revoked
May 16, 2025
Grant Date
Sep 18, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

GREINERJun 18, 2020GREINERADMISSIBLE
SANOFIJun 18, 2020LAVOIXADMISSIBLE

Patent Citations (37) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONEP0125023
DESCRIPTIONEP0239400
DESCRIPTIONEP0404097
DESCRIPTIONJP2005112514
DESCRIPTIONJP2008504970
DESCRIPTIONJPH0159878B
DESCRIPTIONWO2005056604
DESCRIPTIONWO9201047
DESCRIPTIONWO9203918
DESCRIPTIONWO9220791
DESCRIPTIONWO9306213
DESCRIPTIONWO9311161
DESCRIPTIONWO9311236
DESCRIPTIONWO9312227
DESCRIPTIONWO9319172
DESCRIPTIONWO9402602
DESCRIPTIONWO9501438
DESCRIPTIONWO9515388
DESCRIPTIONWO9515393
DESCRIPTIONWO9602576
DESCRIPTIONWO9627011
DESCRIPTIONWO9633735
DESCRIPTIONWO9634096
DESCRIPTIONWO9813388
DESCRIPTIONWO9846777
DESCRIPTIONWO9951743
OPPOSITIONUS11910128
OPPOSITIONUS2002137897
OPPOSITIONUS2003187225
OPPOSITIONUS6485943
OPPOSITIONWO03012069
OPPOSITIONWO03074679
OPPOSITIONWO9627011
OPPOSITIONWO9850431
SEARCHEP1870458
SEARCHEP1900814
SEARCHWO9627011

Non-Patent Literature (NPL) Citations (127) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- ACTA. PHARMACOL. SIN., (2005), vol. 26, no. 6, pages 649 - 58-
DESCRIPTION- ALT M ET AL., FEBS LETTERS, (1999), vol. 454, pages 90 - 94-
DESCRIPTION- AMIT ET AL., SCIENCE, (1986), vol. 233, pages 747 - 53-
DESCRIPTION- ATWELL ET AL., MOL.IMMUNOL., (1996), vol. 33, pages 1301 - 12-
DESCRIPTION- BETTER; HORWITZ, METHODS ENZYMOL., (1989), vol. 178, pages 476 - 96-
DESCRIPTION- BIRD; WALKER, TRENDS BIOTECHNOL., (1991), vol. 9, pages 132 - 7-
DESCRIPTION- BLOOD, (2005), vol. 105, pages 562 - 566-
DESCRIPTION- BRENNAN ET AL., SCIENCE, (1985), vol. 229, page 81-
DESCRIPTION- CANCER RESEARCH, (2000), vol. 60, pages 4336 - 41-
DESCRIPTION- CHOTHIA ET AL., J. MOL. BIOL., (1987), vol. 196, pages 901 - 17-
DESCRIPTION- CHOTHIA ET AL., NATURE, (1989), vol. 342, page 877-
DESCRIPTION- CLACKSON ET AL., NATURE, (1991), vol. 352, pages 624 - 8-
DESCRIPTION- CLIN. CANCER RES., (199602), vol. 2, no. 2, pages 245 - 52-
DESCRIPTION- CO ET AL., J. IMMUNOL., (1994), vol. 152, pages 2968 - 76-
DESCRIPTION- D'ANDREA, AD ET AL., CELL, (1989), vol. 57, pages 277 - 285-
DESCRIPTION- DEMAISON, IMMUNOGETETICS, (1995), vol. 42, pages 342 - 352-
DESCRIPTION- EBERT ET AL., BIO/TECHNOLOGY, (1994), vol. 12, pages 699 - 702-
DESCRIPTION- EMBO. J., (1987), vol. 6, page 2939-
DESCRIPTION- FANTL WI. ET AL., ANNU. REV. BIOCHEM., (1993), vol. 62, pages 453 - 481-
DESCRIPTION- FLOWER DR., BIOCHIM. BIOPHYS. ACTA, (1999), vol. 1422, pages 207 - 234-
DESCRIPTION- FUKUNAGA, R. ET AL., CELL, (1990), vol. 61, pages 341 - 350-
DESCRIPTION- FUKUNAGA, R. ET AL., PROC. NATL. ACAD. SCI. USA., (1990), vol. 87, pages 8702 - 8706-
DESCRIPTION- G KOHLER; C. MILSTEIN, METHODS ENZYMOL., (1981), vol. 73, pages 3 - 46-
DESCRIPTION- GODING, Monoclonal Antibodies: Principles and Practice, ACADEMIC PRESS, (1986), pages 59 - 103-
DESCRIPTION- GRIFFITHS ET AL., EMBO J., (1994), vol. 13, pages 3245 - 60-
DESCRIPTION- GRONWALD, RGK. ET AL., PROC. NATL. ACAD. SCI. USA., (1988), vol. 85, pages 3435 - 3439-
DESCRIPTION- HOLLIGER ET AL., PROC. NATL. ACAD. SCI. USA, (1993), vol. 90, pages 6444 - 8-
DESCRIPTION- HOLLIGER ET AL., PROTEIN ENGINEERING, (1996), vol. 9, pages 299 - 305-
DESCRIPTION- "Hormones and their Actions Part II", COOKE BA.; KING RJB., New Comprehensive Biochemistry, ELSEVIER SCIENCE PUBLISHERS BV., (1988), vol. 18B, pages 1 - 46-
DESCRIPTION- HUDSON ET AL., J. IMMUNOL. METHODS, (1999), vol. 231, pages 177 - 189-
DESCRIPTION- HUDSON ET AL., J IMMUNOL. METHODS, (1999), vol. 231, pages 177 - 89-
DESCRIPTION- HUSTON ET AL., PROC. NATL. ACAD. SCI. USA, (1988), vol. 85, pages 5879 - 83-
DESCRIPTION- J. EXP. MED., (1995), vol. 108, page 945-
DESCRIPTION- J. IMMUNOL. METHODS, (1997), vol. 201, pages 35 - 55-
DESCRIPTION- J. MOL. RECOGNIT., (2003), vol. 16, pages 113 - 120-
DESCRIPTION- JOHN ET AL., PROTEIN ENGINEERING, (1999), vol. 12, no. 7, pages 597 - 604-
DESCRIPTION- JOHNSON ET AL., METHOD IN ENZYMOLOGY, (1991), vol. 203, pages 88 - 98-
DESCRIPTION- JOURNAL OF IMMUNOLOGICAL METHODS, (1999), vol. 231, pages 177 - 89-
DESCRIPTION- KIPPS ET AL., J. CLIN. INVEST., (1991), vol. 87, pages 2087 - 2096-
DESCRIPTION- KREBBER ET AL., J. IMMUNOL. METHODS, (1997), vol. 201, pages 35 - 55-
DESCRIPTION- KREBBER, J. IMMUNOL. METHODS, (1997), vol. 201, pages 35 - 55-
DESCRIPTION- K. SATO ET AL., CANCER RES., (1993), vol. 53, pages 851 - 856-
DESCRIPTION- KUNKEL, PROC. NATL. ACAD. SCI. USA, (1985), vol. 82, page 488-
DESCRIPTION- LAMOYI, METHODS ENZYMOL., (1986), vol. 121, pages 652 - 63-
DESCRIPTION- MA, EUR. J. IMMUNOL., (1994), vol. 24, pages 131 - 138-
DESCRIPTION- MARIETTE ET AL., ARTHRITIS RHEUM., (1993), vol. 36, pages 1315 - 1324-
DESCRIPTION- MARK ET AL., J. MOL. BIOL., (1991), vol. 222, pages 581 - 597-
DESCRIPTION- MARKS, J. MOL. BIOL., (1991), vol. 222, pages 581 - 97-
DESCRIPTION- MASSAGUL J., CELL, (1992), vol. 69, pages 1067 - 1070-
DESCRIPTION- MENDEZ, NAT. GENET., (1997), vol. 15, pages 146 - 56-
DESCRIPTION- MERCHANT AM ET AL., NATURE BIOTECHNOLOGY, (1998), vol. 16, pages 677 - 681-
DESCRIPTION- MIYAJIMA A. ET AL., ANNU. REV. IMMUNOL., (1992), vol. 10, pages 295 - 331-
DESCRIPTION- MOL. CELL BIOL., (1998), vol. 8, pages 466 - 472-
DESCRIPTION- MORIMOTO ET AL., J. BIOCHEM. BIOPHYS. METHODS, (1992), vol. 24, pages 107 - 17-
DESCRIPTION- NIWA ET AL., GENE, (1991), vol. 108, pages 193 - 199-
DESCRIPTION- NOVICK, D. ET AL., CELL, (1994), vol. 77, pages 391 - 400-
DESCRIPTION- ORITA, BLOOD, (2005), vol. 105, pages 562 - 566-
DESCRIPTION- PATTHY L., CELL, (1990), vol. 61, pages 13 - 14-
DESCRIPTION- PERISIC ET AL., STRUCTURE, (1994), vol. 2, pages 1217 - 26-
DESCRIPTION- P. HOLLIGER ET AL., PROC. NATL. ACAD. SCI. USA, (1993), vol. 90, pages 6444 - 6448-
DESCRIPTION- PLICKTHUN, The Pharmacology of Monoclonal Antibodies, SPRINGER VERLAG, (1994), vol. 113, pages 269 - 315-
DESCRIPTION- PLUCKTHUN; SKERRA, METHODS ENZYMOL., (1989), vol. 178, pages 497 - 515-
DESCRIPTION- PLUCKTHUN, The Pharmacology of Monocionai Antibody, SPRINGER VERLAG, (1994), vol. 113, pages 269 - 315-
DESCRIPTION- PLUCKTHUN, The Pharmacology of Monoclonal Antibodies, SPRINGER VERLAG, NEW YORK, (1994), vol. 113, pages 269 - 315-
DESCRIPTION- PROC. NATL. ACAD. SCI. USA., (1984), vol. 81, page 1075-
DESCRIPTION- PROTEIN ENGINEERING, (1996), vol. 9, no. 3, pages 299 - 305-
DESCRIPTION- PROTEIN SCI., (199704), vol. 6, no. 4, pages 781 - 8-
DESCRIPTION- RIDGWAY JB ET AL., PROTEIN ENGINEERING, (1996), vol. 9, pages 617 - 621-
DESCRIPTION- ROUSSEAUX ET AL., METHODS ENZYMOL., (1986), vol. 121, pages 663 - 9-
DESCRIPTION- SATO, K. ET AL., CANCER RES., (1993), vol. 53, pages 851 - 856-
DESCRIPTION- SEGAL DM ET AL., CURRENT OPINION IN IMMUNOLOGY, (1999), vol. 11, pages 558 - 562-
DESCRIPTION- SIMON, S. ET AL., BLOOD, (1990), vol. 76, pages 31 - 35-
DESCRIPTION- SMALL, D. ET AL., PROC. NATL. ACAD. SCI. USA., (1994), vol. 91, pages 459 - 463-
DESCRIPTION- SMITH CA. ET AL., CELL, (1994), vol. 76, pages 959 - 962-
DESCRIPTION- SUSUMU, NATURE, (1985), vol. 315, pages 592 - 594-
DESCRIPTION- TAGA T.; KISHIMOTO T., FASEB J., (1992), vol. 7, pages 3387 - 3396-
DESCRIPTION- ULLRICH A. ET AL., CELL, (1990), vol. 61, pages 203 - 212-
DESCRIPTION- ULLRICH, A. ET AL., NATURE, (1985), vol. 313, pages 756 - 761-
DESCRIPTION- UZE, G ET AL., CELL, (1990), vol. 60, pages 225 - 234-
DESCRIPTION- VALLE ET AL., NATURE, (1981), vol. 291, pages 338 - 340-
DESCRIPTION- VARGAS-MADRAZO E ET AL., J. MOL. RECOGNIT., (2003), vol. 16, pages 113 - 120-
DESCRIPTION- VAUGHAN ET AL., NATURE BIOTECHNOLOGY, (1996), vol. 14, pages 309 - 14-
DESCRIPTION- WATERHOUSES ET AL., NUCLEIC ACIDS RES., (1993), vol. 21, pages 2265 - 6-
DESCRIPTION- WELSCHOF ET AL., J. IMMUNOL. METHOD, (1995), vol. 179, pages 203 - 214-
DESCRIPTION- ZHE Z, PROTEIN SCIENCE, (1997), vol. 6, pages 781 - 788-
OPPOSITION- Gustavo Helguera, "Antibody-Cytokine Fusion Proteins for the Therapy of Cancer", Adoptive Immunotherapy: Methods and Protocols, (20050101), pages 347 - 373, XP055759639-
OPPOSITION- KHALIFA MYRIAM BEN, ET AL, "Effects on interaction kinetics of mutations at the VH-VL interface of Fabs depend on the structural context", JOURNAL OF MOLECULAR RECOGNITION., HEYDEN & SON LTD., LONDON., GB, GB, (20000501), vol. 13, no. 3, ISSN 0952-3499, pages 127 - 139, XP002592197-
OPPOSITION- N Hugo, Et Al, "Functional aspects of co-variant surf ace charges in an antibody fragment", Protein Sci, (20020101), vol. 11, pages 2697 - 2705, XP055261739-
OPPOSITION- Reference table: IMGT exon, EU and Kabat numbering of residues within the human IgG1 sequence, (20200601), URL: http://www.imgt.org/IMGTScientificChart/Numbering/Hu_IGHGnber.html-
OPPOSITION- RIDGWAY ET AL, "'KNOBS-INTO-HOLES' ENGINEERING OF ANTIBODY CH3 DOMAINS FOR HEAVY CHAIN HETERODIMERIZATION", PROTEIN ENGINEERING, OXFORD UNIVERSITY PRESS, SURREY., GB, GB, (19960101), vol. 09., no. 07., ISSN 0269-2139, pages 617 - 621., XP002084766-
OPPOSITION- Sm Chamow et al, "A humanized, bispecific immunoadhesin-antibody that retargets CD3+ effectors to kill HIV-1-infected cells", The Journal of Immunology, American Association of Immunologists, US, US, (19941101), vol. 153, no. 9, ISSN 0022-1767, pages 4268 - 4280, XP055249056-
OPPOSITION- TAN P. H., SANDMALER B. M., STAYTON P. S., "CONTRIBUTIONS OF A HIGHLY CONSERVED VH/VL HYDROGEN BONDING iNTERACTION TO SCFV FOLDING STABILITY AND REFOLDING EFFICIENCY.", BIOPHYSICAL JOURNAL, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL, (19980901), vol. 75., no. 03., ISSN 0006-3495, pages 1473 - 1482., XP000944587-
OPPOSITION- ZHU Z., ET AL., "REMODELING DOMAIN INTERFACES TO ENHANCE HETERODIMER FORMATION.", Protein Science, Wiley, US, US, (19970401), vol. 06., no. 04., ISSN 0961-8368, pages 781 - 788., XP000929847-
OPPOSITION- VARGAS-MADRAZO ENRIQUE E, PAZ-GARCIA E, "An improved model of association for VH-VL immunoglobulin domains: Asymmetries between VH and VL in the packing of some interface residues.", JOURNAL OF MOLECULAR RECOGNITION., HEYDEN & SON LTD., LONDON., GB, GB, (20030501), vol. 16, no. 3, doi:10.1002/JMR.613, ISSN 0952-3499, pages 113 - 120, XP002592198
OPPOSITION- CHATELLIER JEAN ET AL, "Functional mapping of conserved residues located at the VL and VH domain interface of a Fab", Journal of Molecular Biology, Academic Press, United Kingdom, United Kingdom, (19960101), vol. 264, no. 1, doi:10.1006/jmbi.1996.0618, ISSN 0022-2836, pages 1 - 6, XP002592199
OPPOSITION- Worn, A. Pluckthun, A., "Stability engineering of antibody single-chain Fv fragments", Journal of Molecular Biology, Academic Press, United Kingdom, United Kingdom, (20010202), vol. 305, no. 5, doi:10.1006/jmbi.2000.4265, ISSN 0022-2836, pages 989 - 1010, XP004465987
OPPOSITION- O'SHEA E. K., LUMB K. J., KIM P. S., "PEPTIDE 'VELCRO*': DESIGN OF A HETERODIMERIC COILED COIL.", CURRENT BIOLOGY, CURRENT SCIENCE, GB, GB, (19930101), vol. 03., no. 10., doi:10.1016/0960-9822(93)90063-T, ISSN 0960-9822, pages 658 - 667., XP000653001
OPPOSITION- CARTER PAUL, "Bispecific human IgG by design.", JOURNAL OF IMMUNOLOGICAL METHODS., ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM., NL, NL, (20010101), vol. 248, no. 1-2, doi:10.1016/S0022-1759(00)00339-2, ISSN 0022-1759, pages 7 - 15, XP002974199
OPPOSITION- DALL'ACQUA WILLIAM ET AL, "Contribution of domain interface residues to the stability of antibody CH3 domain homodimers.", Biochemistry, (19980630), vol. 37, no. 26, doi:10.1021/bi980270i, ISSN 0006-2960, pages 9266 - 9273, XP002245748
OPPOSITION- ARNDT K M, MUELLER K M ,PLUECKTHUN A, "Factors influencing the dimer to monomer transition of an antibody single-chain Fv fragment.", Biochemistry, (19980915), vol. 37, no. 37, doi:10.1021/bi9810407, ISSN 0006-2960, pages 12918 - 12926, XP002348237
OPPOSITION- Otomo T, Et Al, "Structure of the heterodimeric complex between CAD domains of CAD and ICAD", Nature, doi:10.1038/77957·Source:, (20000101), pages 658 - 662, Nature, URL: https://www.researchgate.net/profile/Shigekazu_Nagata/publication/31942392_Structure_of_the_heterodimeric_complex_between_CAD_domains_of_CAD_and_ICAD/links/546e7d860cf2b5fc1760781d/Structure-of-the-heterodimeric-complex-between-CAD-domains-of-CAD-and-ICAD.pdf, (20201214), XP055759483
OPPOSITION- MERCHANT A MARGARET ET AL, "An efficient route to human bispecific IgG.", Nature Biotechnology, Gale Group Inc., New York, us, us, (19980701), vol. 16, no. 7, doi:10.1038/nbt0798-677, ISSN 1087-0156, pages 677 - 681, XP002141015
OPPOSITION- K. Gunasekaran et al, "Enhancing Antibody Fc Heterodimer Formation through Electrostatic Steering Effects: APPLICATIONS TO BISPECIFIC MOLECULES AND MONOVALENT IgG", Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, (20100618), vol. 285, no. 25, doi:10.1074/jbc.M110.117382, ISSN 0021-9258, pages 19637 - 19646, XP055001947
OPPOSITION- R. Raffen, P. W. Stevens, C. Boogaard, M. Schiffer, F. J. Stevens, "Reengineering immunoglobulin domain interactions by introduction of charged residues", PROTEIN ENGINEERING, DESIGN AND SELECTION, OXFORD JOURNAL, LONDON, GB, GB, (19980401), vol. 11, no. 4, doi:10.1093/protein/11.4.303, ISSN 1741-0126, pages 303 - 309, XP055759474
OPPOSITION- MARVIN JONATHAN S, ZHU Z, "Recombinant approaches to IgG-like bispecific antibodies", Acta Pharmacologica Sinica, Nature Publishing Group, GB, GB, (20050601), vol. 26, no. 6, doi:10.1111/j.1745-7254.2005.00119.x, ISSN 1671-4083, pages 649 - 658, XP002412036
OPPOSITION- RAGHAVAN M., BJORKMAN P. J., "FC RECEPTORS AND THEIR INTERACTIONS WITH IMMUNOGLOBULINS.", ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY., ANNUAL REVIEWS, US, US, (19960101), vol. 12., doi:10.1146/annurev.cellbio.12.1.181, ISSN 1081-0706, pages 181 - 220., XP000676674
SEARCH- KHALIFA MYRIAM BEN ET AL, "Effects on interaction kinetics of mutations at the VH-VL interface of Fabs depend on the structural context", JOURNAL OF MOLECULAR RECOGNITION, (200005), vol. 13, no. 3, ISSN 0952-3499, pages 127 - 139, XP002592197 [Y] 1-16 * the whole document *-
SEARCH- W H Ward ET AL, "Effects of engineering complementary charged residues into the hydrophobic subunit interface of tyrosyl-tRNA synthetase. Appendix: Kinetic analysis of dimeric enzymes that reversibly dissociate into inactive subunits", Biochemistry, UNITED STATES, (19870630), pages 4131 - 4138, URL: http://pubs.acs.org/doi/pdf/10.1021/bi00387a058, XP055276947 [X] 17,18 * abstract *-
SEARCH- ZHU Z ET AL, "REMODELING DOMAIN INTERFACES TO ENHANCE HETERODIMER FORMATION", PROTEIN SCIENCE, WILEY, US, (19970401), vol. 6, no. 4, ISSN 0961-8368, pages 781 - 788, XP000929847 [Y] 1-16 * page 786, column l, paragraph 4 * * page 786, column l, paragraph l - column r, paragraph 2 * * page 786, column l, paragraph 3 *-
SEARCH- KORN T ET AL, "Recombinant bispecific antibodies for the targeting of adenoviruses to CEA-expressing tumour cells: a comparative analysis of bacterially expressed single-chain diabody and tandem scFv", JOURNAL OF GENE MEDICINE, WILEY, US LNKD- DOI:10.1002/JGM.555, (20040101), vol. 6, no. 6, ISSN 1099-498X, pages 642 - 651, XP003005521 [A] 1-16 * the whole document *
SEARCH- VARGAS-MADRAZO ENRIQUE ET AL, "An improved model of association for VH-VL immunoglobulin domains: Asymmetries between VH and VL in the packing of some interface residues.", JOURNAL OF MOLECULAR RECOGNITION, (200305), vol. 16, no. 3, ISSN 0952-3499, pages 113 - 120, XP002592198 [Y] 1-16 * the whole document *
SEARCH- CHATELLIER JEAN ET AL, "Functional mapping of conserved residues located at the VL and VH domain interface of a Fab", JOURNAL OF MOLECULAR BIOLOGY, (1996), vol. 264, no. 1, ISSN 0022-2836, pages 1 - 6, XP002592199 [Y] 1-16 * the whole document *
SEARCH- KIPRIYANOV S M ET AL, "Bispecific tandem diabody for tumor therapy with improved antigen binding and pharmacokinetics", JOURNAL OF MOLECULAR BIOLOGY, LONDON, GB LNKD- DOI:10.1006/JMBI.1999.3156, (19991015), vol. 293, no. 1, ISSN 0022-2836, pages 41 - 56, XP004457324 [Y] 1-16 * the whole document *
SEARCH- WORN A ET AL, "Stability engineering of antibody single-chain Fv fragments", JOURNAL OF MOLECULAR BIOLOGY, LONDON, GB LNKD- DOI:10.1006/JMBI.2000.4265, (20010202), vol. 305, no. 5, ISSN 0022-2836, pages 989 - 1010, XP004465987 [Y] 1-16 * the whole document *
SEARCH- JUNG S ET AL, "The Importance of Framework Residues H6, H7 and H10 in Antibody Heavy Chains: Experimental Evidence for a New Structural Subclassification of Antibody VH Domains", JOURNAL OF MOLECULAR BIOLOGY, LONDON, GB LNKD- DOI:10.1006/JMBI.2001.4665, (20010608), vol. 309, no. 3, ISSN 0022-2836, pages 701 - 716, XP004626896 [Y] 1-16 * abstract * * page 712, paragraph 3 *
SEARCH- KIPRIYANOV S M ET AL, "Effect of Domain Order on the Activity of Bacterially Produced Bispecific Single-chain Fv Antibodies", JOURNAL OF MOLECULAR BIOLOGY, LONDON, GB LNKD- DOI:10.1016/S0022-2836(03)00526-6, (20030627), vol. 330, no. 1, ISSN 0022-2836, pages 99 - 111, XP004445110 [Y] 1-16 * the whole document *
SEARCH- ARNDT K M ET AL, "Factors influencing the dimer to monomer transition of an antibody single-chain Fv fragment", BIOCHEMISTRY, AMERICAN CHEMICAL SOCIETY, US LNKD- DOI:10.1021/BI9810407, (19980915), vol. 37, no. 37, ISSN 0006-2960, pages 12918 - 12926, XP002348237 [Y] 1-16 * the whole document *
SEARCH- DAVIES J ET AL, "ANTIBODY VH DOMAINS AS SMALL RECOGNITION UNITS", BIO/TECHNOLOGY, NATURE PUBLISHING CO. NEW YORK, US LNKD- DOI:10.1038/NBT0595-475, (19950501), vol. 13, no. 5, ISSN 0733-222X, pages 475 - 479, XP002011336 [Y] 1-16 * abstract *
SEARCH- SAL-MAN N ET AL, "Arginine mutations within a transmembrane domain of Tar, an Escherichia coli aspartate receptor, can drive homodimer dissociation and heterodimer association in vivo", BIOCHEMICAL JOURNAL, THE BIOCHEMICAL SOCIETY, LONDON, GB LNKD- DOI:10.1042/BJ20041022, (20050101), vol. 385, no. PART 1, ISSN 0264-6021, pages 29 - 36, XP003005868 [Y] 1-16 * abstract *
SEARCH- NOHAILE M J ET AL, "Altering dimerization specificity by changes in surface electrostatics", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, US, (20010313), vol. 98, no. 6, doi:10.1073/PNAS.051624498, ISSN 0027-8424, pages 3109 - 3114, XP002412033 [X] 17,18 * abstract * [Y] 1-16
SEARCH- MCPHEE F ET AL, "Engineering human immunodeficiency virus 1 protease heterodimers as macromolecular inhibitors of viral maturation", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, US, (19961001), vol. 93, doi:10.1073/PNAS.93.21.11477, ISSN 0027-8424, pages 11477 - 11481, XP002126434 [X] 17,18 * page 11478, column r, paragraph 2 * * page 11478, column l, paragraph 1 - paragraph 2 * [Y] 1-16
SEARCH- KUMAR R ET AL, "The second PDZ domain of INAD is a type I domain involved in binding to eye protein kinase C. Mutational analysis and naturally occurring variants", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, INC, US LNKD- DOI:10.1074/JBC.M103570200, (20010101), vol. 276, no. 27, ISSN 0021-9258, pages 24971 - 24977, XP003005869 [Y] 1-16 * abstract *
SEARCH- NIEBA L ET AL, "Disrupting the hydrophobic patches at the antibody variable/constant domain interface: Improved in vivo folding and physical characterization of an engineered scFv fragment", PROTEIN ENGINEERING, OXFORD UNIVERSITY PRESS, SURREY, GB LNKD- DOI:10.1093/PROTEIN/10.4.435, (19970101), vol. 10, no. 4, ISSN 0269-2139, pages 435 - 444, XP002249462 [Y] 1-16 * abstract *
SEARCH- WU A M ET AL, "Multimerization of a chimeric anti-CD20 single-chain Fv-Fc fusion protein is mediated through variable domain exchange", PROTEIN ENGINEERING, OXFORD UNIVERSITY PRESS, SURREY, GB LNKD- DOI:10.1093/PROTEIN/14.12.1025, (20010101), vol. 14, no. 12, ISSN 0269-2139, pages 1025 - 1033, XP002982160 [Y] 1-16 * the whole document *
SEARCH- LE GALL FABRICE ET AL, "Effect of linker sequences between the antibody variable domains on the formation, stability and biological activity of a bispecific tandem diabody", PROTEIN ENGINEERING, DESIGN AND SELECTION, OXFORD JOURNAL, LONDON, GB LNKD- DOI:10.1093/PROTEIN/GZH039, (20040401), vol. 17, no. 4, ISSN 1741-0126, pages 357 - 366, XP002429042 [Y] 1-16 * the whole document *
SEARCH- KONTERMANN ROLAND E, "Recombinant bispecific antibodies for cancer therapy", ACTA PHARMACOLOGICA SINICA, NATURE PUBLISHING GROUP, US, CN LNKD- DOI:10.1111/J.1745-7254.2005.00008.X, (20050101), vol. 26, no. 1, ISSN 1671-4083, pages 1 - 9, XP002426874 [A] 1-16 * the whole document *
SEARCH- SINHA NEETI ET AL, "ELECTROSTATICS IN PROTEIN BINDING AND FUNCTION", CURRENT PROTEIN AND PEPTIDE SCIENCE, BENTHAM SCIENCE PULBISHERS, NL, (20021201), vol. 3, no. 6, doi:10.2174/1389203023380431, ISSN 1389-2037, pages 601 - 614, XP008077600 [Y] 1-16 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents